171 related articles for article (PubMed ID: 26791014)
1. Design, synthesis and biological evaluation of 1,3,6-trisubstituted β-carboline derivatives for cytotoxic and anti-leishmanial potential.
Lunagariya NA; Gohil VM; Kushwah V; Neelagiri S; Jain S; Singh S; Bhutani KK
Bioorg Med Chem Lett; 2016 Feb; 26(3):789-794. PubMed ID: 26791014
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and biological evaluation of piperazinyl-β-carbolinederivatives as anti-leishmanial agents.
Ashok P; Chander S; Smith TK; Sankaranarayanan M
Eur J Med Chem; 2018 Apr; 150():559-566. PubMed ID: 29549840
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and anti-leishmanial evaluation of 1-phenyl-2,3,4,9-tetrahydro-1H-β-carboline derivatives against Leishmania infantum.
Ashok P; Chander S; Tejería A; García-Calvo L; Balaña-Fouce R; Murugesan S
Eur J Med Chem; 2016 Nov; 123():814-821. PubMed ID: 27541264
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and anti-leishmanial activity of 1-aryl-β-carboline derivatives against Leishmania donovani.
Gohil VM; Brahmbhatt KG; Loiseau PM; Bhutani KK
Bioorg Med Chem Lett; 2012 Jun; 22(12):3905-7. PubMed ID: 22608390
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of 2-(pyrimidin-2-yl)-1-phenyl-2,3,4,9-tetrahydro-1H-beta-carbolines as antileishmanial agents.
Kumar R; Khan S; Verma A; Srivastava S; Viswakarma P; Gupta S; Meena S; Singh N; Sarkar J; Chauhan PM
Eur J Med Chem; 2010 Aug; 45(8):3274-80. PubMed ID: 20457476
[TBL] [Abstract][Full Text] [Related]
6. Syntheses of new substituted triazino tetrahydroisoquinolines and beta-carbolines as novel antileishmanial agents.
Kumar A; Katiyar SB; Gupta S; Chauhan PM
Eur J Med Chem; 2006 Jan; 41(1):106-13. PubMed ID: 16356594
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, antileishmanial and antitrypanosomal activities of N-substituted tetrahydro-β-carbolines.
Manda S; Khan SI; Jain SK; Mohammed S; Tekwani BL; Khan IA; Vishwakarma RA; Bharate SB
Bioorg Med Chem Lett; 2014 Aug; 24(15):3247-50. PubMed ID: 24980054
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and in vitro cytotoxic evaluation of 1,3-bisubstituted and 1,3,9-trisubstituted beta-carboline derivatives.
Cao R; Peng W; Chen H; Hou X; Guan H; Chen Q; Ma Y; Xu A
Eur J Med Chem; 2005 Mar; 40(3):249-57. PubMed ID: 15725494
[TBL] [Abstract][Full Text] [Related]
9. Anti-Leishmanial and Cytotoxic Activities of a Series of Maleimides: Synthesis, Biological Evaluation and Structure-Activity Relationship.
Fan Y; Lu Y; Chen X; Tekwani B; Li XC; Shen Y
Molecules; 2018 Nov; 23(11):. PubMed ID: 30400596
[TBL] [Abstract][Full Text] [Related]
10. Biological evaluation and structure activity relationship of 9-methyl-1-phenyl-9H-pyrido[3,4-b]indole derivatives as anti-leishmanial agents.
Ashok P; Chander S; Smith TK; Prakash Singh R; Jha PN; Sankaranarayanan M
Bioorg Chem; 2019 Mar; 84():98-105. PubMed ID: 30500524
[TBL] [Abstract][Full Text] [Related]
11. Preparation and antiprotozoal evaluation of promising β-carboline alkaloids.
Gellis A; Dumètre A; Lanzada G; Hutter S; Ollivier E; Vanelle P; Azas N
Biomed Pharmacother; 2012 Jul; 66(5):339-47. PubMed ID: 22397756
[TBL] [Abstract][Full Text] [Related]
12. Novel β-carboline-quinazolinone hybrids disrupt Leishmania donovani redox homeostasis and show promising antileishmanial activity.
Ramu D; Garg S; Ayana R; Keerthana AK; Sharma V; Saini CP; Sen S; Pati S; Singh S
Biochem Pharmacol; 2017 Apr; 129():26-42. PubMed ID: 28017772
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antikinetoplastid activities of 3-substituted quinolinones derivatives.
Audisio D; Messaoudi S; Cojean S; Peyrat JF; Brion JD; Bories C; Huteau F; Loiseau PM; Alami M
Eur J Med Chem; 2012 Jun; 52():44-50. PubMed ID: 22472166
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and anti-leishmanial activity of novel symmetrical bispyridinium cyclophanes.
Gómez-Pérez V; Manzano JI; García-Hernández R; Castanys S; Gamarro F; Campos JM
Eur J Med Chem; 2015 Jan; 89():362-9. PubMed ID: 25462252
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, antileishmanial activity and mechanism of action studies of novel β-carboline-1,3,5-triazine hybrids.
Baréa P; Barbosa VA; Bidóia DL; de Paula JC; Stefanello TF; da Costa WF; Nakamura CV; Sarragiotto MH
Eur J Med Chem; 2018 Apr; 150():579-590. PubMed ID: 29549842
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and in vitro and in vivo antitumor activities of novel beta-carboline derivatives.
Cao R; Chen H; Peng W; Ma Y; Hou X; Guan H; Liu X; Xu A
Eur J Med Chem; 2005 Oct; 40(10):991-1001. PubMed ID: 15950325
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and structure-activity relationship studies of novel 3,9-substituted α-carboline derivatives with high cytotoxic activity against colorectal cancer cells.
Lin YC; Chen YF; Tseng LS; Lee YH; Morris-Natschke SL; Kuo SC; Yang NS; Lee KH; Huang LJ
Eur J Med Chem; 2016 Mar; 110():98-114. PubMed ID: 26820553
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of novel β-carboline based chalcones with high cytotoxic activity against breast cancer cells.
Chauhan SS; Singh AK; Meena S; Lohani M; Singh A; Arya RK; Cheruvu SH; Sarkar J; Gayen JR; Datta D; Chauhan PM
Bioorg Med Chem Lett; 2014 Jul; 24(13):2820-4. PubMed ID: 24844196
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and evaluation of amino-substituted 1H-phenalen-1-ones as anti-leishmanial agents.
Freijo MB; López-Arencibia A; Piñero JE; McNaughton-Smith G; Abad-Grillo T
Eur J Med Chem; 2018 Jan; 143():1312-1324. PubMed ID: 29126735
[TBL] [Abstract][Full Text] [Related]
20. Syntheses of novel β-carboline derivatives and the activities against five tumor-cell lines.
Bai B; Li XY; Liu L; Li Y; Zhu HJ
Bioorg Med Chem Lett; 2014 Jan; 24(1):96-8. PubMed ID: 24345445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
